EXPLORE THE SCIENCE

TriNetX

Drugs & MedicationsJuly 11, 2026

GLP-1RAs Linked to Lower Heart Failure Risk in Obstructive Sleep Apnea

TL;DR: A 2026 real-world study in Journal of Clinical Sleep Medicine found that glucagon-like peptide-1 receptor agonist use was associated with lower 3-year cardiovascular-event risk in adults with obesity and obstructive sleep apnea. Key Findings 18,523 matc…

Read article

Drugs & MedicationsJune 11, 2026

GLP-1 Receptor Agonists Linked to Small Hypersomnolence Risk Increase

TL;DR: A 2026 real-world cohort study in Journal of Diabetes & Metabolic Disorders linked GLP-1 receptor agonists, drugs targeting a glucose-related metabolic hormone pathway, to a higher hazard of new hypersomnolence, but the absolute risk increase was small.…

Read article

GLP-1RAs Linked to Lower Heart Failure Risk in Obstructive Sleep Apnea

GLP-1 Receptor Agonists Linked to Small Hypersomnolence Risk Increase

The findings. The context. The caveats.